Waldencast plc Announces Fourth Quarter and Fiscal Year 2025 Earnings Date
Rhea-AI Summary
Waldencast (NASDAQ: WALD) said it will release Fourth Quarter and Fiscal Year 2025 results on March 13, 2026 before U.S. market open. The company also said it will not host a conference call to discuss results due to its ongoing strategic review.
Positive
- None.
Negative
- None.
News Market Reaction – WALD
In the Mar 12 session, WALD declined 3.95%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Nov 24 | Q2/H1 2025 results | Negative | -6.5% | Reported H1 net loss with large goodwill impairments and mixed brand trends. |
| May 13 | Q1 2025 results | Positive | -20.8% | Q1 2025 results with high margins, EBITDA, new credit facility, and 2025 guidance. |
| Mar 18 | Q4/FY 2024 results | Positive | -3.2% | Strong Q4 and full‑year 2024 growth and EBITDA with positive brand performance. |
| Nov 20 | Q3 2024 results | Positive | +0.9% | Q3 2024 showed strong comparable revenue growth and margin expansion. |
| Aug 27 | Q2 2024 results | Positive | +5.5% | Q2 2024 delivered strong comparable growth and higher Adjusted EBITDA margin. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Earnings releases often showed negative price reactions even on strong growth metrics, with several selloffs following otherwise solid quarterly reports.
Recent earnings history for Waldencast shows strong growth in 2024, with Q2–Q4 delivering double‑digit revenue gains and expanding Adjusted EBITDA. However, 2025 results introduced pressure: Q1 revenue declined year over year, and by Q2/H1 2025 the company reported large goodwill impairments and a significant net loss, alongside a strategic review. Today’s announcement simply schedules Q4 and FY 2025 results, which follow this transition from high growth to restructuring and balance sheet actions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
LONDON, March 11, 2026 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform announced that its Fourth Quarter and Fiscal Year 2025 earnings will be issued in a press release on March 13, 2026, prior to U.S. market open. The Company does not plan to host a conference call to discuss results given its ongoing strategic review.
About Waldencast plc
Founded by Michel Brousset and Hind Sebti, Waldencast’s ambition is to build a global best-in-class beauty and wellness operating platform by developing, acquiring, accelerating, and scaling conscious, high-growth purpose-driven brands. Waldencast’s vision is fundamentally underpinned by its brand-led business model that ensures proximity to its customers, business agility, and market responsiveness, while maintaining each brand’s distinct DNA. The first step in realizing its vision was the business combination with Obagi Medical and Milk Makeup. As part of the Waldencast platform, its brands will benefit from the operational scale of a multi-brand platform; the expertise in managing global beauty brands at scale; a balanced portfolio to mitigate category fluctuations; asset light efficiency; and the market responsiveness and speed of entrepreneurial indie brands. For more information please visit: https://ir.waldencast.com/.
Contacts
Investors
ICR
Allison Malkin
waldencastir@icrinc.com
Media
ICR
Brittany Fraser
Waldencast@icrinc.com
